Modified Citrus Pectin (MCP), is a nondigestible, water-soluble polysaccharide fiber derived from citrus fruit found to inhibit breast tumor growth and metastasis (Nangia-Makker, 2002). Modified Citrus Pectin (MCP), also known as fractionated pectin, is a complex polysaccharide obtained from the peel and pulp of citrus fruits. Modified citrus pectin is rich in galactoside residues. Metastasis is one of the most life-threatening aspects of cancer and the lack of effective anti-metastatic therapies has prompted research on MCP’s effectiveness in blocking metastasis of certain types of cancers, including melanomas, prostate, and breast cancers. (Garnham, 2019).
MCP’s apparent safety and proven anti-metastatic action, and the lack of other proven therapies against metastasis, justifies its inclusion in comprehensive orthomolecular anticancer regimens.
These galactoside residues can preferentially bind to the lectins on the cell membranes of the unwanted cells, in turn preventing the attachment of the unwanted cells to normal cells, thus inhibiting the growth of these cells.
Recommendation: 5 grams, twice per day